Aerovate Therapeutics Ownership | Who Owns Aerovate Therapeutics?

Aerovate Therapeutics Ownership Summary

Aerovate Therapeutics is owned by 1.71% institutional investors, 0.02% insiders, and 98.28% retail investors. Blackrock is the largest institutional shareholder, holding 3.54% of AVTE shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.85% of its assets in Aerovate Therapeutics shares.

AVTE Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Aerovate Therapeutics	1.71%	0.02%	98.28%
Sector	Healthcare Stocks	279.42%	10.64%	-190.05%
Industry	Biotech Stocks	64.05%	10.69%	25.27%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	983.06K	3.54%	$1.63M
Artal group	809.60K	2.91%	$1.34M
Goldman sachs group	314.37K	1.09%	$833.08K
Alliancebernstein	69.91K	0.24%	$185.26K
Susquehanna group, llp	57.75K	0.20%	$153.04K
Bnp paribas arbitrage, snc	54.69K	0.19%	$144.92K
Morgan stanley	51.77K	0.19%	$85.94K
Fifth lane capital, lp	50.00K	0.18%	$83.00K
Nuveen asset management	40.05K	0.14%	$106.12K
Cubist systematic strategies	31.89K	0.11%	$52.94K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Fifth lane capital, lp	50.00K	0.12%	$83.00K
Artal group	809.60K	0.03%	$1.34M
Gg group ventures	13.09K	0.03%	$22.91K
Quarry lp	22.50K	0.01%	$37.35K
Cubist systematic strategies	31.89K	0.00%	$52.94K
Lmr partners llp	14.10K	0.00%	$23.41K
Tower research capital llc (trc)	3.87K	0.00%	$10.24K
Alliancebernstein	69.91K	0.00%	$185.26K
Bnp paribas arbitrage, snc	54.69K	0.00%	$144.92K
Goldman sachs group	314.37K	0.00%	$833.08K

Top Buyers

Holder	Shares	% Assets	Change
Artal group	809.60K	0.03%	809.60K
Blackrock	983.06K	-	273.31K
Goldman sachs group	314.37K	0.00%	153.36K
Susquehanna group, llp	57.75K	-	57.75K
Bnp paribas arbitrage, snc	54.69K	0.00%	54.69K

Top Sellers

Holder	Shares	% Assets	Change
Ra capital management	-	-	-9.19M
Sofinnova investments	-	-	-3.76M
Tcg crossover management	-	-	-2.24M
Atlas venture life science advisors	-	-	-1.80M
Adar1 capital management	-	-	-1.46M

New Positions

Holder	Shares	% Assets	Change	Value
Artal group	809.60K	0.03%	809.60K	$1.34M
Bnp paribas arbitrage, snc	54.69K	0.00%	54.69K	$144.92K
Fifth lane capital, lp	50.00K	0.12%	50.00K	$83.00K
Cubist systematic strategies	31.89K	0.00%	31.89K	$52.94K
Quarry lp	22.50K	0.01%	22.50K	$37.35K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-2.00
True wealth design	-9.00
Advisor group	-12.00
Sterling capital management	-13.00
Eversource wealth advisors	-30.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	8	-90.36%	17,315,633	-42.60%	1	0.02%	3	-94.12%	1	-92.31%
Dec 31, 2024	82	6.49%	30,155,830	9.09%	104	1.14%	50	28.21%	13	-18.75%
Sep 30, 2024	77	-17.20%	27,644,291	1.70%	95	1.00%	39	-37.10%	16	14.29%
Jun 30, 2024	93	17.72%	27,181,983	-4.43%	97	0.93%	62	55.00%	14	-39.13%
Mar 31, 2024	79	25.40%	28,443,127	0.96%	102	0.89%	40	29.03%	23	35.29%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	536.62K	1.85%	52.67K
iShares Russell 2000 ETF	458.98K	1.58%	-3.96K
Vanguard VIF Small Co Gr	213.89K	0.74%	-76.53K
Vanguard Institutional Extnd Mkt Idx Tr	202.52K	0.70%	-
State St Russell Sm/Mid Cp® Indx SL Cl I	172.19K	0.59%	-
State St Russell Sm/Mid Cp® Indx NL Cl C	172.19K	0.59%	-
Bridge Builder Tax Managed Sm/Md Cp	124.13K	0.43%	-
iShares Russell 2000 Growth ETF	110.99K	0.38%	-528.00
Vanguard Russell 2000 ETF	62.88K	0.22%	1.38K
Fidelity Enhanced Small Cap ETF	48.26K	0.17%	-336.00

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 17, 2024	RA CAPITAL MANAGEMENT, L.P.		Buy	$1.55M
Jun 14, 2024	Eldridge George A	SEE REMARKS	Sell	$375.45K
Jun 14, 2024	Verwijs Marinus	CHIEF TECHNICAL OFFICER	Sell	$265.00K
Jun 13, 2024	Gillies Hunter	CHIEF MEDICAL OFFICER	Sell	$147.00K
May 17, 2024	Gillies Hunter	CHIEF MEDICAL OFFICER	Sell	$82.45K

Insider Transactions Trends

Date	Buy	Sell
2024 Q3	-	-
2024 Q2	1	29
2024 Q1	-	23
2023 Q4	-	12
2023 Q3	-	10

AVTE Ownership FAQ

Who Owns Aerovate Therapeutics?

Aerovate Therapeutics shareholders are primarily institutional investors at 1.71%, followed by 0.02% insiders and 98.27% retail investors. The average institutional ownership in Aerovate Therapeutics's industry, Biotech Stocks , is 64.05%, which Aerovate Therapeutics falls below.

Who owns the most shares of Aerovate Therapeutics?

Aerovate Therapeutics’s largest shareholders are Blackrock (983.06K shares, 3.54%), Artal group (809.6K shares, 2.91%), and Goldman sachs group (314.37K shares, 1.09%). Together, they hold 7.54% of Aerovate Therapeutics’s total shares outstanding.

Does Blackrock own Aerovate Therapeutics?

Yes, BlackRock owns 3.54% of Aerovate Therapeutics, totaling 983.06K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.63M$. In the last quarter, BlackRock increased its holdings by 273.31K shares, a 38.51% change.

Who is Aerovate Therapeutics’s biggest shareholder by percentage of total assets invested?

Fifth lane capital, lp is Aerovate Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.12% of its assets in 50K Aerovate Therapeutics shares, valued at 83K$.

Who is the top mutual fund holder of Aerovate Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Aerovate Therapeutics shares, with 1.85% of its total shares outstanding invested in 536.62K Aerovate Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools